CareDx PE Ratio 2013-2025 | CDNA

Current and historical p/e ratio for CareDx (CDNA) from 2013 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. CareDx PE ratio as of June 13, 2025 is 16.37.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

CareDx PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-06-13 18.59 16.17
2025-03-31 17.75 $1.15 15.43
2024-12-31 21.41 $1.02 20.99
2024-09-30 31.23 $-2.70 0.00
2024-06-30 15.53 $-2.99 0.00
2024-03-31 10.59 $-3.42 0.00
2023-12-31 12.00 $-3.54 0.00
2023-09-30 7.00 $-1.67 0.00
2023-06-30 8.50 $-1.56 0.00
2023-03-31 9.14 $-1.51 0.00
2022-12-31 11.41 $-1.44 0.00
2022-09-30 17.02 $-1.41 0.00
2022-06-30 21.48 $-1.32 0.00
2022-03-31 36.99 $-0.95 0.00
2021-12-31 45.48 $-0.59 0.00
2021-09-30 63.37 $-0.35 0.00
2021-06-30 91.52 $-0.18 0.00
2021-03-31 68.09 $-0.29 0.00
2020-12-31 72.45 $-0.42 0.00
2020-09-30 37.94 $-0.46 0.00
2020-06-30 35.43 $-0.44 0.00
2020-03-31 21.83 $-0.48 0.00
2019-12-31 21.57 $-0.52 0.00
2019-09-30 22.61 $-0.50 0.00
2019-06-30 35.99 $-1.00 0.00
2019-03-31 31.52 $-1.21 0.00
2018-12-31 25.14 $-1.33 0.00
2018-09-30 28.85 $-2.37 0.00
2018-06-30 12.24 $-2.46 0.00
2018-03-31 7.97 $-2.25 0.00
2017-12-31 7.34 $-2.21 0.00
2017-09-30 3.70 $-1.81 0.00
2017-06-30 1.11 $-1.44 0.00
2017-03-31 1.40 $-2.01 0.00
2016-12-31 2.70 $-2.56 0.00
2016-09-30 3.55 $-2.23 0.00
2016-06-30 4.31 $-2.26 0.00
2016-03-31 4.96 $-1.77 0.00
2015-12-31 6.40 $-1.15 0.00
2015-09-30 4.17 $-0.75 0.00
2015-06-30 6.50 $-0.34 0.00
Sector Industry Market Cap Revenue
Medical Medical Services $1.048B $0.334B
CareDx, Inc. is a commercial stage company. It develops, markets, and delivers a diagnostic surveillance solution for heart transplant recipients. The Company provides AlloMap, a noninvasive blood test used to aid in the identification of heart transplant recipients. It is also pursuing other areas of transplant surveillance, such as the use of cell-free DNA (cfDNA) as a biomarker for rejection. CareDx, Inc. is based in Brisbane, California.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $146.784B 27.53
Elevance Health (ELV) United States $87.260B 11.26
CVS Health (CVS) United States $83.934B 10.43
Cencora (COR) United States $57.186B 19.90
Natera (NTRA) United States $22.441B 0.00
DiDi Global (DIDIY) China $22.121B 23.50
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.895B 0.00
Solventum (SOLV) United States $12.853B 13.61
ICON (ICLR) Ireland $11.879B 11.04
CochLear (CHEOY) Australia $11.671B 0.00
Revvity (RVTY) United States $11.280B 19.41
Doximity (DOCS) United States $10.697B 49.52
Viatris (VTRS) United States $10.669B 3.67
Avantor (AVTR) United States $9.227B 13.41
HealthEquity (HQY) United States $8.993B 39.39
Medpace Holdings (MEDP) United States $8.737B 23.21
Sonic Healthcare (SKHHY) Australia $8.503B 0.00
Charles River Laboratories (CRL) United States $7.460B 14.62
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.400B 25.92
BrightSpring Health Services (BTSG) United States $3.797B 34.84
Sotera Health (SHC) United States $3.335B 18.95
Alignment Healthcare (ALHC) United States $2.983B 0.00
Surgery Partners (SGRY) United States $2.961B 38.50
Concentras Parent (CON) United States $2.793B 16.14
Organon (OGN) United States $2.618B 2.78
Ardent Health (ARDT) United States $1.938B 8.26
GeneDx Holdings (WGS) United States $1.894B 72.93
Premier (PINC) United States $1.855B 14.08
Progyny (PGNY) United States $1.847B 40.66
PACS (PACS) United States $1.614B 0.00
GoodRx Holdings (GDRX) United States $1.600B 32.00
Teladoc Health (TDOC) United States $1.258B 0.00
Pediatrix Medical (MD) United States $1.224B 9.31
Establishment Labs Holdings (ESTA) $1.073B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.011B 0.00
Agilon Health (AGL) United States $0.907B 0.00
AMN Healthcare Services Inc (AMN) United States $0.828B 7.75
QDM (QDMI) Hong Kong, SAR China $0.763B 0.00
Nutex Health (NUTX) United States $0.694B 10.51
Embecta (EMBC) United States $0.587B 3.95
LifeMD (LFMD) United States $0.577B 0.00
Enhabit (EHAB) United States $0.505B 41.54
InnovAge Holding (INNV) United States $0.498B 0.00
Auna S.A (AUNA) Luxembourg $0.469B 10.57
Sonida Senior Living (SNDA) United States $0.467B 0.00
SBC Medicals (SBC) United States $0.464B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.423B 0.00
Performant Healthcare (PHLT) United States $0.257B 0.00
Oncology Institute (TOI) United States $0.236B 0.00
Beauty Health (SKIN) United States $0.197B 0.00
DocGo (DCGO) United States $0.154B 25.17
KindlyMD (KDLY) United States $0.150B 0.00
Pheton Holdings (PTHL) China $0.111B 0.00
KindlyMD (NAKA) United States $0.102B 0.00
So-Young (SY) China $0.095B 0.00
Basel Medical Group (BMGL) Singapore $0.087B 0.00
OncoCyte (OCX) United States $0.077B 0.00
Sera Prognostics (SERA) United States $0.067B 0.00
Ascend Wellness Holdings (AAWH) United States $0.063B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.055B 0.00
ModivCare (MODV) United States $0.048B 0.00
Biodesix (BDSX) United States $0.044B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.029B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
INVO Fertility (IVF) United States $0.003B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00